CVM
CVM
AMEX · Biotechnology

Cel-Sci Corp

$1.16
-0.03 (-2.52%)
Analyst Consensus
Strong Buy
5
Analysts
Moderate
Coverage
Buy 4 80%
Hold 1 20%
Sell 0 0%
Price Target
Analyst Price Target +3,815.5% upside
Low Target $30.66
Average Target $45.42
High Target $56.99
Current Price $1.16
Current
$1.16
Target
$45.42
$30.66 $45.42 avg $56.99
Scenario Analysis
Bear Case
$30.66
2,543.1%
Low target
Base Case
$45.42
+3,815.5%
Avg target
Bull Case
$56.99
+4,812.9%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$7.80
-85.1% from high
52-Week Low
$0.89
+30.3% from low
Target vs 52W High
$45.42
+482.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -19.2%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%